minocycline sold brand name minocin among others tetracycline antibiotic medication used treat number bacterial infections generally always less preferred tetracycline minocycline also used treatment acne rheumatoid taken mouth applied common side effects include nausea diarrhea dizziness allergic reactions kidney serious side effects may include anaphylaxis lupuslike syndrome easy use later part pregnancy may harm baby safety breastfeeding works decreasing bacteriums ability make protein thus stopping minocycline patented came commercial use available generic commonly prescribed medication united states million united states minocycline indicated treat inflammatory lesions nonnodular moderate severe acne vulgaris people nine years age minocycline doxycycline frequently used treatment acne closely related antibiotics similar levels efficacy although doxycycline slightly lower risk adverse side historically minocycline effective treatment acne however acne caused antibioticresistant bacteria growing problem many europe north america number people acne longer respond well treatment tetracycline family antibiotics acne symptoms caused bacteria primarily cutibacterium acnes resistant antibiotics order reduce resistance rates well increase effectiveness treatment oral antibiotics generally combined topical acne creams benzoyl peroxide retinoid tretinoin adapalene minocycline also used skin infections methicillinresistant staphylococcus although minocyclines broader spectrum activity compared members group includes activity neisseria use prophylaxis longer recommended side effects dizziness vertigo may used treat certain strains methicillinresistant aureus infection disease caused drugresistant acinetobacter list uses includes minocycline doxycycline shown effectiveness asthma due immunesuppressing minocycline doxycycline modest effectiveness treating rheumatoid however american college rheumatology guideline treatment rheumatoid arthritis include recent research indicate centrally infused minocycline attenuates brain microglial activation neuroinflammation sympathetic activation pulmonary drug contraindicated people known hypersensitivity tetracycline antibiotics complete cross sensitivity group also contraindicated people severe liver impairment week minocycline may cause upset stomach diarrhea dizziness unsteadiness drowsiness mouth sores headache vomiting increases sensitivity sunlight may affect quality sleep rarely causes sleep also linked cases prolonged use minocycline lead bluegray staining skin fingernails scar tissue staining permanent take long time skin color return normal however muddy brown skin color sunexposed areas usually permanent blue discoloration gums teeth discoloration may also occur rare serious side effects include fever yellowing eyes skin stomach pain sore throat vision changes mental changes including occasionally minocycline therapy may result autoimmune disorders drugrelated lupus autoimmune hepatitis usually occurs men also developed minocyclineinduced lupus however women likely develop minocyclineinduced lupus significant complete recovery occurs people develop minocyclineinduced autoimmune problems within period weeks year cessation minocycline therapy autoimmune problems emerge chronic therapy sometimes occur short courses couple weeks drug reaction eosinophilia systemic symptoms syndrome occur first weeks therapy minocycline tetracyclines cause vestibular disturbances dizziness ataxia vertigo tinnitus effects thought related minocyclines greater penetration central nervous system vestibular side effects much common women men occurring women receiving minocycline result frequency bothersome side effect minocycline rarely used female symptoms allergic reaction include rash itching swelling severe dizziness trouble minocycline also reported rarely cause idiopathic intracranial hypertension pseudotumor side effect also common female patients potentially leading permanent vision damage recognized early contrary tetracycline antibiotics doxycycline excluded minocycline may used kidney disease may aggravate systemic lupus may also trigger unmask autoimmune minocycline cause rare condition secondary intracranial hypertension initial symptoms headache visual disturbances dizziness vomiting brain swelling rheumatoid arthritis rare side effects minocycline minocycline like tetracyclines becomes dangerous past expiration prescription drugs lose potency expiration dates tetracyclines known become toxic time expired tetracyclines cause serious damage kidney due formation degradation product minocyclines absorption impaired taken time day calcium iron supplements unlike tetracycline group antibiotics taken calciumrich foods milk although reduce absorption minocycline like tetracyclines associated esophageal irritation ulceration insufficient fluids taken drug study suggested minocycline harms amyotrophic lateral sclerosis patients patients minocycline declined rapidly placebo mechanism side effect unknown although hypothesis drug exacerbated autoimmune component primary disease effect seem dosedependent patients high doses worse low use minocycline acne vulgaris associated skin gut dysbiosis see antibiotic combination minocycline dairy antacids calcium magnesium supplements iron products laxatives containing magnesium bile acid sequestrants may decrease minocyclines effectiveness forming chelates combining isotretinoin acitretin retinoids increase risk intracranial hypertension minocycline significantly reduces concentrations antihiv drug atazanavir minocycline quickly nearly completely absorbed upper part small intestine taking together food including milk relevant influence resorption reaches highest blood plasma concentrations one two hours plasma protein binding substance penetrates almost tissues high concentrations found gallbladder liver crosses barrier better doxycycline tetracyclines reaching therapeutically relevant concentrations cerebrospinal fluid also inflamed minocycline inactivated metabolization liver rest predominantly excreted gut part via gallbladder part directly blood vessels eliminated via feces eliminated via kidneys biological halflife hours healthy people hours kidney significantly longer liver drug used form minocycline hydrochloride sparingly soluble water slightly soluble ethanol minocycline reacts acidic aqueous minocycline patented came commercial use topical foam treatment acne approved available generic early research found tentative benefit minocycline several trials metaanalysis found minocycline may reduce negative total symptom scores well research examining possible neuroprotective antiinflammatory effects minocycline progression group neurodegenerative disorders including multiple sclerosis rheumatoid arthritis huntingtons disease parkinsons mentioned minocycline harms als patientscitation needed minocycline also known indirectly inhibit inducible nitric oxide trial found difference minocycline placebo people alzheimers minocycline also used lastditch treatment toxoplasmosis aids minocycline somewhat neuroprotective mouse models huntingtons study reported impact antibiotic minocycline clinical magnetic resonance imaging mri outcomes serum immune molecules ms patients months openlabel minocycline treatment despite moderately high pretreatment relapse rate patient group prior treatment preenrollment threemonth baseline period relapses occurred months minocycline also despite significant mri diseaseactivity pretreatment scans gadoliniumenhancing activity threemonth runin patient gadoliniumenhancing lesions mri months halfdose minocycline levels high levels might antagonize proinflammatory receptor elevated months treatment levels soluble vascular cell adhesion activity matrix decreased treatment clinical mri outcomes study supported systemic immunological changes call investigation minocycline minocycline studied treatmentresistant depression according systematic review based four clinical trials significant difference minocycline compared placebo depression responding firstline antidepressant ongoing research trial minocycline demonstrated efficacy seems promising neuroprotective agent acute stroke patients especially ais subgroup rcts needed evaluate efficacy safety minocycline among ich httpsenwikipediaorgwikiminocycline